BIOBANK Renal Transplantation University Hospitals Leuven

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Universitaire Ziekenhuizen Leuven
Sponsor:
Information provided by (Responsible Party):
Prof Dr Maarten Naesens, Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier:
NCT01331668
First received: April 6, 2011
Last updated: March 25, 2014
Last verified: March 2014
  Purpose

This study aims to maintain a prospective biobank of human samples obtained from donors and recipients of renal allografts, including biopsy tissue, peripheral blood samples and urine samples.


Condition
Kidney Failure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Biobank Renal Transplantation University Hospitals Leuven

Resource links provided by NLM:


Further study details as provided by Universitaire Ziekenhuizen Leuven:

Primary Outcome Measures:
  • Renal allograft survival [ Time Frame: 50 years after transplantation ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Biopsy material (tissue, RNA, DNA) Peripheral blood samples (serum, plasma, RNA, DNA) Urine samples


Estimated Enrollment: 5000
Study Start Date: March 2004
Estimated Study Completion Date: December 2099
Estimated Primary Completion Date: December 2099 (Final data collection date for primary outcome measure)
Groups/Cohorts
renal allograft donors and recipients
All de novo renal allograft recipients transplanted at the University Hospitals Leuven

Detailed Description:

Clinical data and bio-specimens are prospectively collected and stored for undefined future translational research projects.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All donors and recipients of a kidney transplant at the University Hospitals Leuven

Criteria

Inclusion Criteria:

  • renal transplant recipients/donors

Exclusion Criteria:

  • none
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01331668

Contacts
Contact: Maarten Naesens, MD, PhD 32 16344580 maarten.naesens@uzleuven.be

Locations
Belgium
Department of Nephrology and Renal Transplantation - University Hospitals Leuven Recruiting
Leuven, BE, Belgium, 3000
Contact: Maarten Naesens, MD, PhD    32 16344580    maarten.naesens@uzleuven.be   
Principal Investigator: Maarten Naesens, MD, PhD         
Principal Investigator: Dirk Kuypers, MD, PhD         
Sponsors and Collaborators
Universitaire Ziekenhuizen Leuven
Investigators
Principal Investigator: Maarten Naesens, MD, PhD University Hospitals Leuven
  More Information

Publications:

Responsible Party: Prof Dr Maarten Naesens, Prof. Dr. Maarten Naesens, Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier: NCT01331668     History of Changes
Other Study ID Numbers: TRA-UZL-BIOBANK-001
Study First Received: April 6, 2011
Last Updated: March 25, 2014
Health Authority: Belgium: Federal Agency for Medicines and Health Products, FAMHP

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on September 18, 2014